Hepatic artery thrombosis after liver transplantation: More than just a surgical complication?

Transplant International

Volumn 22, Issue 2, 2009, Pages 162-164

  Lisman, Ton ^a   Porte, Robert J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; ARTERY ANASTOMOSIS; ARTERY THROMBOSIS; BLOOD CLOTTING TEST; HEMOSTASIS; HEPATIC ARTERY; HEPATIC ARTERY THROMBOSIS; HEREDITY; HUMAN; LIVER TRANSPLANTATION; MORBIDITY; NOTE; PRIORITY JOURNAL; PROTHROMBIN TIME;

AMYLOID NEUROPATHIES, FAMILIAL; HEPATIC ARTERY; HUMANS; LIVER TRANSPLANTATION; THROMBOSIS;

EID: 58149277062     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2008.00762.x     Document Type: Note

References (15)

1. Pastacaldi S, Teixeira R, Montalto P, Rolles K, Burroughs AK. Hepatic artery thrombosis after orthotopic liver transplantation: a review of nonsurgical causes. Liver Transpl 2001 7 : 75.
2. Warnaar N, Lisman T, Porte RJ. The two tales of coagulation in liver transplantation. Curr Opin Organ Transplant 2008 13 : 298.
3. Tripodi A, Mannucci PM. Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research. J Hepatol 2007 46 : 727.
4. Hirshfield G, Collier JD, Brown K, et al. Donor factor V Leiden mutation and vascular thrombosis following liver transplantation. Liver Transpl Surg 1998 4 : 58.
5. Tanyel FC, Ocal T, Balkanci F, et al. The factor V Leiden mutation: a possible contributor to the hepatic artery thrombosis encountered after liver transplantation in a child. J Pediatr Surg 2000 35 : 607.
6. Stahl RL, Duncan A, Hooks MA, Henderson JM, Millikan WJ, Warren WD. A hypercoagulable state follows orthotopic liver transplantation. Hepatology 1990 12 : 553.
7. Kassis J, Hirsh J, Podor TJ. Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell type I plasminogen activator inhibitor biosynthesis. Blood 1992 80 : 1758.
8. Bispo M, Marcelino P, Freire A, Martins A, Mourao L, Barroso E. High incidence of thrombotic complications early after liver transplantation for familial amyloidotic polyneuropathy. Transplant Int doi :.
9. Sucker C, Hetzel GR, Grabensee B, Stockschlaeder M, Scharf RE. Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy. Am J Kidney Dis 2006 47 : 947.
10. Zangari M, Elice F, Fink L, Tricot G. Hemostatic dysfunction in paraproteinemias and amyloidosis. Semin Thromb Hemost 2007 33 : 339.
11. Adachi N, Shoji S, Yanagisawa N. Bleeding manifestations in 24 patients with familial amyloidotic polyneuropathy. Eur Neurol 1988 28 : 115.
12. Herczenik E, Bouma B, Korporaal SJ, et al. Activation of human platelets by misfolded proteins. Arterioscler Thromb Vasc Biol 2007 27 : 1657.
13. Saraiva MJ, Costa PP, Goodman DS. Studies on plasma transthyretin (prealbumin) in familial amyloidotic polyneuropathy, Portuguese type. J Lab Clin Med 1983 102 : 590.
14. Lisman T, de Groot PG. Hemostatic dysfunction related to liver diseases and liver transplantation. In : Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, eds. Hematology. New York, NY : McGraw-Hill, 2006 : 1953 1958.
15. Vivarelli M, La BG, Cucchetti A, et al. Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? Liver Transpl 2007 13 : 651.